Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors

Pain

Volumn 136, Issue 3, 2008, Pages 232-234

  Staud, Roland ^a   Price, Donald D ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;

ACUPUNCTURE; ANALGESIA; CLINICAL TRIAL; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; PRIORITY JOURNAL; SOMNOLENCE;

ADRENERGIC UPTAKE INHIBITORS; ANALGESICS; CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; FIBROMYALGIA; GAMMA-AMINOBUTYRIC ACID; HUMANS; LONGITUDINAL STUDIES; OUTCOME ASSESSMENT (HEALTH CARE); PLACEBO EFFECT; THIOPHENES; TREATMENT OUTCOME;

EID: 43549113560     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.03.005     Document Type: Editorial

References (14)

1. Arnold L.M., Goldenberg D.L., Stanford S.B., Lalonde J., Sandhu H.S., Keck P.E., et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 56 (2007) 1336-1344
2. Arnold L.M., Rosen A., Pritchett Y.L., D'Souza D.N., Goldstein D.J., Iyengar S., et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119 (2005) 5-15
3. Bausell R.B., Lao L., Bergman S., Lee W.L., and Berman B.M. Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants' perceived assignments in two placebo-controlled trials. Eval Health Prof 28 (2005) 9-26
4. Carette S., Bell M.J., Reynolds W.J., Haraoui B., McCain G.A., Bykerk V.P., et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 37 (1994) 32-40
5. Crofford L.J., Mease P.J., Simpson S.L., Young J.P., Martin S.A., Haig G.M., et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-months, double-blind, placebo-controlled trial with pregabalin. Pain 136 (2008) 419-431
6. Crofford L.J., Simpson S., Young J.P., Haig G., and Sharma U. A six-month, double-blind, placebo-controlled, durability of effect study of pregabalin for pain associated with fibromyalgia. Arthritis Rheum 54 (2006) L44
7. Dworkin R.H., Corbin A.E., Young J.P., Sharma U., LaMoreaux L., Bockbrader H., et al. Pregabalin for the treatment of postherpetic neuralgia - a randomized, placebo-controlled trial. Neurology 60 (2003) 1274-1283
8. Leber P.D., and Davis C.S. Threats to the validity of clinical trials employing enrichment strategies for sample selection. Control Clin Trials 19 (1998) 178-187
9. Lesser H., Sharma U., LaMoreaux L., and Poole R.M. Pregabalin relieves symptoms of painful diabetic neuropathy - a randomized controlled trial. Neurology 63 (2004) 2104-2110
10. Linde K., Witt C.M., Streng A., Weidenhammer W., Wagenpfeil S., Brinkhaus B., et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128 (2007) 264-271
11. Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP, Martin SA, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol, in press.
12. Price D.D., Finniss D.G., and Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 59 (2008) 565-590
13. Russell I.J., Mease P.J., Smith T.R., Kajdasz D.K., Wohlreich M.D., Detke M.J., et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136 (2008) 432-444
14. Vitton O., Gendreau M., Gendreau J., Kranzler J., and Rao S.G. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 19 (2004) S27-S35